Hansa-3 (NG): India's Indigenous Trainer Aircraft

Hansa-3 (NG): India's Indigenous Trainer Aircraft

07-04-2025
  1. The Council of Scientific and Industrial Research (CSIR), in collaboration with the National Aerospace Laboratories (NAL), has signed a technology transfer deal with a private firm to manufacture the HANSA-3 trainer aircraft in India.
  2. This marks a historic achievement as the HANSA-3 is the first aircraft to be fully designed and developed indigenously in India and will be manufactured based on this local technology.

Key Features of HANSA-3 (NG)

  1. Engine: The aircraft is powered by the Rotax 912 iSc3 Sports engine, which is known for its fuel efficiency, contributing to lower operational costs and environmental sustainability.
  2. Performance:
    1. Range: The aircraft has a range of 620 nautical miles, making it suitable for various training requirements.
    2. Endurance: It boasts an impressive 7 hours of endurance, ensuring long-duration training sessions.
    3. Speed: The aircraft achieves a maximum cruise speed of 98 Knots Calibrated Airspeed (KCAS), suitable for its role as a trainer.

Significance of HANSA-3 (NG)

  1. Flying Training Ecosystem: The HANSA-3 contributes to the creation of a world-class flying training ecosystem in India, enhancing the quality and capacity of aviation training.
  2. Strengthening India's Aviation Industry: By manufacturing this trainer aircraft locally, India takes a significant step toward self-reliance in its aviation sector, boosting both the industry and the economy.
  3. Indigenous Technology:
    The HANSA-3 aircraft is a testament to India's growing capabilities in aerospace technology, marking a new chapter in the development of indigenous aviation solutions.

 

Also Read

FREE NIOS Books

UPSC Daily Current Affairs

UPSC Monthly Magazine

Previous Year Interview Questions

Free MCQs for UPSC Prelims

UPSC Test Series

ENSURE IAS NOTES

Our Booklist

 

Prime Minister's Inauguration of Projects in Amaravati, Andhra Pradesh

Government of Karnataka Notifies Hesaraghatta Grassland Conservation Reserve

Cancer Patients in UK to Receive Immunotherapy Drugs via Single Injection for Faster Treatment